XGN (exagen.com) Company Short-Term Debts

XGN (Exagen Inc.) - company brandmark

The linear price action on the Exagen Inc. (XGN) chart helps assess the company's debt load, which currently stands at 0.00. The business specializes in identifying autoimmune pathologies, utilizing high-performance software to expand its client base without increasing headcount. Operational activities are shielded from external trade restrictions, as all research is conducted exclusively within US jurisdiction.

XGN exagen.com Company Short-Term Debt (07/04/2022 - 10/31/2026)

Metric breakdowns and analytics for Exagen Inc (XGN)

- current quotes and average value forecast:
Price Chart Exagen Diagnostics|XGN - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization Exagen|XGN - Enterprise Value
- business book valuation details:
Net Assets per Single Share Exagen Inc.|XGN - Company Book Value|Market Cap to Net Assets Ratio exagen.com|XGN - Company Assets
- debt level and financial liquidity data:
Debt to Equity Exagen Inc.|XGN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Exagen Diagnostics|XGN - Company Total Debt Obligations|Debt to Book Capitalization Ratio Exagen|XGN - Long-Term Debt Volume|Company Short-Term Debts Exagen Inc.|Quick Liquidity Indicator exagen.com
- earnings and multiples data:
XGN - Company Profit
Fundamental company analysis:XGN - exagen.com
Mass-produced product of Exagen Inc

Exagen Inc. specializes in developing high-tech diagnostic systems for cardiology, where margins are driven by AI algorithms. Analyzing the short-term debt chart allows for an assessment of the operational burden on the business to service obligations due within one year. The current value of 0.00 reflects the volume of credit resources required for reagent procurement and payroll. The trend of this indicator demonstrates the efficiency of liquidity management amid patent growth. Controlling these payments is critical to minimizing interest rate risks as the company scales.

Competitors of Exagen Inc.

A - Company Short-Term Debt|DGX (Quest Diagnostics Inc.) - Company Short-Term Indebtedness|ILMN: Company Short-Term Debts|Exact Sciences Inc. (EXAS) - Company Short-Term Debts|Company Short-Term Debt Revvity, Inc.|Company Short-Term Debt BIO|Company Current Liabilities NNNN (Anbio)|SHC - Short-Term Debt|Company Short-Term Debt QuidelOrtho Corp QDEL|Short-Term Debt Volume OPKO Health Corp. (OPK)|CareDx, Inc. - Company Short-Term Debts|Short-Term Debt Volume maravai.com MRVI|Fulgent Genetics (FLGT) - Company Short-Term Debt|LAB - Short-Term Debt Volume|CTKB (Cytek Bio) - Company Short-Term Debts|Short-Term Debt OraSure Corp OSUR|Company Current Liabilities MDXH (MDxHealth SA)|luciddx.com - Company Short-Term Indebtedness|Company Short-Term Debts PRE (Prenetics)|Company Short-Term Debts Insight Molecular Diagnostics, Inc. IMDX|Trinity Biotech Corp - Company Short-Term Debts|Short-Term Indebtedness ProPhase Labs Corp (PRPH)|AIMD: Company Short-Term Debts|Short-Term Debt codiagnostics.com (CODX)|Company Short-Term Debt HeartSciences|Company Short-Term Indebtedness BMRA (Biomerica Inc.)|Company Current Liabilities CDIO (Cardio Diagnostics)|VRAX (Virax Biolabs Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BJDX (Bluejay Diagnostics)|Short-Term Debt Volume aspirawh.com (AWH)|AXDX - Company Short-Term Debt|CNTG (CENTOGENE N.V.) - Company Short-Term Indebtedness|ENZ: Company Short-Term Debts|Company Current Liabilities Fresh2 Group|Company Current Liabilities GENE|23andme.com (ME) - Short-Term Debt Volume|Company Current Liabilities PMD (Psychemedics Corporation)